The administration of IL-33 helps myelin repair by inducing the transcription of myelin genes and promoting the differentiation of OPC to form mature myelin forming cells, indicating its neuroprotective effect in MS [93]. This evidence concerns the gene IL33 and myeloid sarcoma.